US Stock MarketDetailed Quotes
ARMP Armata Pharmaceuticals
- 2.680
- -0.040-1.47%
Close Nov 14 16:00 ET
96.97MMarket Cap-2330P/E (TTM)
2.764High2.680Low1.75KVolume2.730Open2.720Pre Close4.78KTurnover0.02%Turnover RatioLossP/E (Static)36.18MShares4.48052wk High-1.90P/B29.57MFloat Cap1.93052wk Low--Dividend TTM11.04MShs Float392.000Historical High--Div YieldTTM3.09%Amplitude0.001Historical Low2.723Avg Price1Lot Size
About Armata Pharmaceuticals Company
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.
Company Profile
SymbolARMP
Company NameArmata Pharmaceuticals
Listing DateAug 21, 2015
Issue Price6.00
Founded1989
CEODr. Deborah L. Birx, M.D.
MarketAMEX
Employees66
Fiscal Year Ends12-31
Address5005 McConnell Avenue
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90066
Phone1-310-655-2928
Websitehttp://www.armatapharma.com
Company Executives
-
Name
- Position
- Salary
-
Dr. Deborah L. Birx, M.D.
- Chief Executive Officer and Director
- 1.13M
-
Dr. Mina Pastagia
- Chief Medical Officer
- 463.75K
-
David D. House
- Senior Vice President, Finance and Principal Financial Officer
- --
-
Robin C. Kramer
- Chairman of the Board
- 105.50K
-
Jules Haimovitz
- Independent Director
- 74.88K
-
Dr. Sarah J. Schlesinger, M.D.
- Independent Director
- 66.19K
-
Dr. Odysseas D. Kostas, M.D.
- Independent Director
- 64.19K
-
Dr. Joseph M. Patti,PhD
- Independent Director
- 86.19K
-
Dr. Todd C. Peterson, PhD
- Independent Director
- 73.19K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data